2026 Cost Guide · Last verified July 17, 2026

Brand-Name GLP-1 Under $300 per Month: What Actually Qualifies in 2026

By WPG Research Team · Published: May 29, 2026 · Last updated: July 17, 2026 · FDA-approved products only · Medication and care fees kept separate

For informational purposes only — not medical advice.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We earn a commission from some links, which never changes your price. Our picks come from the verified facts and criteria on this page — and we point you to cheaper routes that pay us nothing, like ordering direct from the drugmaker, whenever those are the better deal. How we make money.

Yes — you can get a brand-name GLP-1 under $300 per month in 2026. The two cheapest real options are FDA-approved pills: the Wegovy pill and Foundayo, both starting around $149 a month, plus the Zepbound 2.5 mg starter vial at $299. If your insurance covers weight-loss medicine, a savings card can bring any of them to as little as $25 for eligible patients.

Here is the part the ads don't show you. "$300" almost always means the medicine only. Add a doctor visit or a monthly membership, or step up to your full dose, and that number can climb. There is a point — usually around your third or fourth refill — where the price can jump, and almost none of the "starting at $149" pages warn you about it. We show you exactly which brand-name drugs stay under $300, at which doses, and where the hidden costs hide.

The 30-second answer

Can you really get a brand-name GLP-1 under $300 per month?

Short answer: yes, but “under $300” can mean four very different things. It might be the medicine only, a starter dose, a limited-time intro price, or a price with conditions attached. The honest version separates the sticker price from the real ongoing cost — what you will actually pay every month once your dose settles and any doctor or membership fee is added.

“Brand-name” means an FDA-approved finished medicine sold under its official name — Wegovy, Zepbound, Foundayo. These passed the FDA's full review for safety, quality, and effectiveness. That is different from compounded semaglutide or tirzepatide, which are custom-mixed versions that are not FDA-approved. We keep compounded products off this page on purpose.

Three ways to measure “under $300”

1. Medicine-only price — the cost of one standard refill. Nothing else.
2. First-month price — medicine plus your first visit or intro membership.
3. Ongoing price — medicine plus the recurring care fee, after your dose goes up and any intro deal ends. This is the one that matters most, and it is the one nobody advertises.

Every brand-name GLP-1 under $300 by dose (2026)

“Under $300” means one standard medicine refill is $300 or less. It does not automatically include a doctor visit, membership, injection supplies, or taxes.

These are cost observations, not medical advice about which drug is right for you.

Is a $299 fill really $299 every month?

Not exactly. The drugmakers price these by their defined one-month supply, and that supply isn't always a calendar month. The pills (Foundayo and Wegovy tablets) come as a 30-day supply. The injection pens (Wegovy and Zepbound) come as a 28-day supply — four weekly doses.

A 28-day fill means you refill about every four weeks, which works out to roughly 13 refills a year, not 12. So a “$299” injection is closer to $3,887 a year — about $324 a month when you average it out — even though each fill is $299. The pills, at 30 days, land closer to $3,588 a year. Our cost calculator does this math for you so you see both numbers.

Which brand-name GLP-1s are under $300 without insurance?

The under-$300 cash options are concentrated in the new daily pills. The Wegovy pill and Foundayo have several doses at or below $299. Zepbound only qualifies at its starting dose, and the Wegovy pen only qualifies for a short intro window. Everything else needs insurance or Medicare to get under $300.

The Wegovy pill (oral semaglutide)

The Wegovy pill is the first oral GLP-1 receptor agonist FDA-approved for chronic weight management. Through Novo Nordisk's NovoCare Pharmacy, the two lowest doses run $149 for a 30-day supply through August 31, 2026, and higher doses go up to $299. With commercial insurance that covers it plus a savings card, it can be as little as $25. It is also the clearest path to a brand-name drug that stays under $300 even at your ongoing dose — no needles required.

Foundayo (orforglipron)

Foundayo is Eli Lilly's once-daily GLP-1 pill. The FDA approved it on April 1, 2026 for adults with obesity, or overweight (BMI 27+) with a weight-related condition. Self-pay starts at $149 for a 30-day supply of the lowest dose, with higher doses running $199 to around $299 (the two highest doses can cost more). It can be taken any time of day, with or without food — no 30-minute morning wait required. One caveat if you take birth control pills: Foundayo can make oral contraceptives less effective (more in the safety section).

Zepbound — why “$299” isn't an ongoing plan

Zepbound's 2.5 mg dose costs $299 — but 2.5 mg is a starting dose, not a dose you stay on. The label uses it to begin treatment and directs an increase after four weeks, based on your prescriber's plan.

The moment you step up, the price does too: the 5 mg dose is $399, and higher doses are $449 (as long as you refill within 45 days; miss that window and it costs more). If someone quotes you “$299 Zepbound” and stops there, they've told you a third of the story.

The Wegovy pen — why “$199” is temporary

The Wegovy pen (the weekly injection) has a $199 intro price for new patients' first two fills at the 0.25 mg or 0.5 mg starter doses. After that, standard cash pricing steps up to $349. The higher-dose Wegovy HD (7.2 mg) is $399. Confirm the current intro window before you count on it — these promos shift.

What we left off this list (on purpose)

• Compounded semaglutide or tirzepatide — not FDA-approved (a separate category).
• Ozempic and Mounjaro for weight loss — those are diabetes-labeled drugs used off-label. Wegovy and Zepbound are the FDA-approved weight-management versions.
• Saxenda — its old savings offer is no longer open to new patients; no verified cash route under $300.
• “Generic Wegovy” or “generic Zepbound” — these don't exist. There are no FDA-approved generics.

What's the true monthly cost after the doctor or membership fee?

A $299 medicine stops being an under-$300 plan the second you add a recurring care fee. The formula is simple:

Your real monthly cost = medicine price + any recurring membership or visit fee. (Not counting taxes, labs, injection supplies, or your deductible.)

Using a $149, $199, or $299 medicine as examples — medicine-only prices from the drugmaker.

If you already have a prescription and just want the lowest number, ordering direct from the drugmaker wins — there is no membership stacked on top. If you need a prescriber and hate subscriptions, Walgreens' $49 pay-per-visit model is the lightest-weight paid route (available in most states for self-pay adults ages 18–64, medicine billed separately). If you want ongoing care and help fighting your insurance, a membership can earn its keep.

One more real cost people forget: the injections need supplies. A Zepbound KwikPen needs a fresh pen needle for each weekly dose, and vials need syringes. Those aren't included in the medicine price — or in the Medicare Bridge benefit.

Choose your route:

Will it still be under $300 after my dose goes up?

Sometimes — and this is where the real bargains separate from the fake ones. The Wegovy pill reaches a maintenance dose still around $299. Foundayo can hold at $299 at most doses. But Zepbound rises above $300 the moment you step up from the starter dose, and the Wegovy pen rises after its first two fills.

See the pattern? The pills bend but hold. The injections start cheap and climb. If a stable, under-$300 cost is your top priority and you are open to a pill, the math clearly favors the Wegovy pill or Foundayo. If you need an injection, the honest answer is you will probably need insurance to keep it under $300.

Real dates that can change your answer

Which under-$300 route fits my situation?

Foundayo vs. the Wegovy pill: which daily pill costs less?

Both pills have cash prices at or below $299, so price alone won't pick a winner. They are taken differently and titrate differently, and the better medical fit depends on your health. Use this to walk into a prescriber visit informed.

Which is easier to fit into your day? This is a real difference. The Wegovy pill has to be taken first thing in the morning on an empty stomach, with a small sip of water, then you wait 30 minutes before anything else. Foundayo can be taken any time, with or without food. If a rigid morning routine is a dealbreaker for you, that is worth raising with your prescriber.

Which has the more predictable ongoing price? The Wegovy pill reaches a clear maintenance dose around $299. Foundayo holds at $299 at most doses, though its two highest doses can cost more.

One thing to know if you take birth control pills: Foundayo's label says it can make oral birth control less effective. It advises switching to a non-pill method or adding a barrier method for 30 days after you start and after each dose increase. Bring this up before you choose.

Can a weekly GLP-1 injection stay under $300 per month?

Not reliably on cash alone, once you are past the starter pricing. Zepbound's $299 applies to the 2.5 mg starting dose only, and the Wegovy pen's $199 is limited to your first two fills. For an ongoing weekly injection under $300, insurance or the Medicare Bridge is the realistic path.

If you are set on an injection and cost is the wall you keep hitting, the smartest next move isn't a coupon. It's finding out whether your insurance will cover it, because that can take a $349 injection down toward $25.

Can commercial insurance bring a brand-name GLP-1 below $300?

Yes — and when your plan covers the drug on good terms, insurance can beat every cash option, sometimes landing near $25. But it depends on whether your specific plan covers the drug for weight loss, whether it requires prior authorization, and the maximum a savings card will knock off.

Can Medicare patients get a brand-name GLP-1 for $50?

Some eligible Medicare Part D members can get a covered weight-loss GLP-1 for a flat $50 monthly copay through the Medicare GLP-1 Bridge, a temporary federal program running July 1, 2026 through December 31, 2027. Eligibility is narrower than just “having Medicare,” and prior authorization is required — but for those who qualify, it is the cheapest brand-name route there is.

What does “brand-name” mean, and why aren't compounded GLP-1s here?

On this page, “brand-name” means an FDA-approved finished medicine sold under its official name. We leave compounded products off because they are not FDA-approved finished drugs, and mixing them into a brand-name ranking would blur a line that matters for your safety and your wallet.

The FDA has been clear that compounded drugs are not FDA-approved and don't go through the same review for safety, effectiveness, and quality before they are sold. The agency has also warned telehealth companies against marketing compounded products as the “same as” or a “generic version” of approved GLP-1 drugs.

Compounded semaglutide can be cheaper, and for some people it is a real option. But it is a separate choice with its own tradeoffs. See our honest, separate breakdown of compounded GLP-1 cost and safety →

What should you check before choosing by price?

A low price doesn't mean a medicine is right for you. These are prescription drugs with real risks, and a licensed clinician still needs to confirm they are appropriate for your health.

This guide compares access and cost. It is not medical advice and does not replace the prescribing information or a licensed clinician's judgment about what is right for you.

How did we verify these prices?

Every medical and regulatory fact here comes from the FDA or another authoritative source, and every price comes from the drugmaker's or provider's own current terms. We keep facts and our opinions clearly separated, and our math is reproducible so you can check it yourself.

Our source order (most trusted first):

FDA approvals and drug labels → Medicare.gov and CMS → official drugmaker price and savings terms → official provider pricing → pharmacy service pages. We never use forums or reviews as evidence for medical, safety, or pricing claims.

The math we used

• Medicine-only total = the listed price of one standard refill.
• First-month total = medicine + your first visit or intro membership.
• Ongoing total = medicine + the recurring care fee, at your maintenance dose.
• Annual monthly avg = total annual cost (accounting for 13 fills/year for 28-day supply) ÷ 12.
• “Under $300” = the total is $300 or less — not “starting at.”

Sources

• U.S. FDA — Foundayo (orforglipron) approval April 1, 2026; Foundayo prescribing information (boxed warning, dosing, contraception); FDA statement on unapproved/compounded GLP-1 drugs; FDA Drug Safety Communication removing suicidal-ideation warning (January 13, 2026)
• Eli Lilly / LillyDirect — Zepbound and Foundayo self-pay terms and pricing
• Novo Nordisk / NovoCare Pharmacy — Wegovy pill and pen self-pay pricing
• Walgreens Weight Management — $49 visit pricing, medication pricing, and eligibility
• Ro — weight-loss membership pricing and free GLP-1 Insurance Coverage Checker
• Sesame — weight-loss program pricing
• Medicare.gov / CMS / Medicare Rights Center — weight-loss drug coverage and the Medicare GLP-1 Bridge (eligibility, covered drugs, cost rules)
• KFF — GLP-1 employer coverage data (fewer than 1 in 4 employers cover GLP-1s for weight loss)

Frequently asked questions

What is the cheapest brand-name GLP-1 in 2026?

The lowest starting price in this category is $149 a month, and both the Wegovy pill and Foundayo reach it at their early doses. "Cheapest to start" and "cheapest to stay on" can differ — check the price-climb table before deciding.

Which brand-name GLP-1 stays under $300 after month three?

The Wegovy pill reaches a maintenance dose around $299, and Foundayo holds at $299 at most doses. Weekly injections (Zepbound, Wegovy pen) generally rise above $300 on cash once starter or intro pricing ends.

Is the Wegovy pill really $149?

Yes, for the two lowest doses through August 31, 2026, under Novo Nordisk's current offer. Higher doses run up to $299, and a separate doctor or membership fee may apply.

Is Zepbound really $299 a month?

Yes for the 2.5 mg starting dose (vial or KwikPen) only. The next dose up is $399, and higher doses are $449, so $299 is a starter price, not an ongoing one.

Does a $299 price cover 28 or 30 days?

It depends. The pills (Foundayo and Wegovy tablets) come as a 30-day supply. The injection pens (Wegovy and Zepbound) come as a 28-day supply — about 13 refills a year instead of 12.

Does the $149 or $299 price include a doctor?

Usually not. Drugmaker medicine prices and telehealth care fees are separate, so add them together to get your real monthly cost.

Does the Zepbound KwikPen include needles?

No. You buy pen needles separately, one for each weekly dose, and they are not part of the Medicare Bridge benefit.

Can I get a weekly brand-name GLP-1 under $300 without insurance?

Only briefly, through the current cash intro offers. A reliable ongoing injection under $300 generally needs insurance coverage or the Medicare Bridge.

Will a savings card guarantee a $25 copay?

No. Savings cards have a monthly cap plus yearly and per-fill limits. If your remaining copay is higher than the monthly cap, you'll pay more than $25 — though it's still usually a large discount, and only for eligible patients with commercial insurance.

Does a cash GLP-1 purchase count toward my insurance deductible?

Often not. Cash and savings-card purchases frequently don't count toward your deductible or out-of-pocket max — check with your plan.

Can Medicare patients pay $50?

Some qualifying Part D members can, through the Medicare GLP-1 Bridge, if they meet the BMI-based criteria and get prior authorization approved. The $50 copay does not count toward your Part D deductible or out-of-pocket limit.

Is Foundayo FDA-approved?

Yes. The FDA approved Foundayo (orforglipron) on April 1, 2026, for adults with obesity or overweight with a weight-related condition.

Is Ozempic included on this page?

No. Ozempic is approved for type 2 diabetes and is used off-label for weight loss. The on-label semaglutide product for weight management is Wegovy, which we do cover.

Are compounded GLP-1s included?

No. This page covers FDA-approved brand-name drugs only. Compounded semaglutide and tirzepatide are a separate category with a separate guide.

Can I pay with an HSA or FSA?

It depends on the specific expense, the route, your documentation, and your plan administrator, so confirm at checkout and with your plan before you count on it.

What happens when the 2026 offers expire?

The listed price may change. We re-check every program before its deadline and update the "last verified" date, so check that date before acting.

The bottom line

The clearest cash-pay path to a brand-name GLP-1 that stays at or below $300 after you reach your full dose is an FDA-approved daily pill — not a weekly injection. The Wegovy pill tops out around $299, and Foundayo holds at $199–$299 at most doses. A weekly injection can start under $300, but it usually needs insurance or the Medicare Bridge to stay there. And “under $300” only holds if you remember to add the doctor or membership fee — so compare the medicine, the care route, your dose path, and the offer dates, not just the number in the ad.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.